Literature DB >> 1323707

Identification of the Rev transactivation and Rev-responsive elements of feline immunodeficiency virus.

T R Phillips1, C Lamont, D A Konings, B L Shacklett, C A Hamson, P A Luciw, J H Elder.   

Abstract

Spliced messages encoded by two distinct strains of feline immunodeficiency virus (FIV) were identified. Two of the cDNA clones represented mRNAs with bicistronic capacity. The first coding exon contained a short open reading frame (orf) of unknown function, designated orf 2. After a translational stop, this exon contained the L region of the env orf. The L region resides 5' to the predicted leader sequence of env. The second coding exon contained the H orf, which began 3' to env and extended into the U3 region of the long terminal repeat. The in-frame splicing of the L and H orfs created the FIV rev gene. Site-directed antibodies to the L orf recognized a 23-kDa protein in infected cells. Immunofluorescence studies localized Rev to the nucleoli of infected cells. The Rev-responsive element (RRE) of FIV was initially identified by computer analysis. Three independent isolates of FIV were searched in their entirety for regions with unusual RNA-folding properties. An unusual RNA-folding region was not found at the Su-TM junction but instead was located at the end of env. Minimal-energy foldings of this region revealed a structure that was highly conserved among the three isolates. Transient expression assays demonstrated that both the Rev and RRE components of FIV were necessary for efficient reporter gene expression. Cells stably transfected with rev-deleted proviruses produced virion-associated reverse transcriptase activity only when FIV Rev was supplied in trans. Thus, FIV is dependent on a fully functional Rev protein and an RRE for productive infection.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1323707      PMCID: PMC289103     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  41 in total

Review 1.  Tat and Rev: positive regulators of HIV gene expression.

Authors:  C A Rosen; G N Pavlakis
Journal:  AIDS       Date:  1990-06       Impact factor: 4.177

2.  Characterization of a cDNA clone encoding the visna virus transactivating protein.

Authors:  J L Davis; J E Clements
Journal:  Proc Natl Acad Sci U S A       Date:  1989-01       Impact factor: 11.205

3.  A highly conserved RNA folding region coincident with the Rev response element of primate immunodeficiency viruses.

Authors:  S Y Le; M H Malim; B R Cullen; J V Maizel
Journal:  Nucleic Acids Res       Date:  1990-03-25       Impact factor: 16.971

4.  RNA amplification with transcript sequencing (RAWTS).

Authors:  G Sarkar; S S Sommer
Journal:  Nucleic Acids Res       Date:  1988-06-10       Impact factor: 16.971

5.  Improved predictions of secondary structures for RNA.

Authors:  J A Jaeger; D H Turner; M Zuker
Journal:  Proc Natl Acad Sci U S A       Date:  1989-10       Impact factor: 11.205

6.  The HIV-1 rev trans-activator acts through a structured target sequence to activate nuclear export of unspliced viral mRNA.

Authors:  M H Malim; J Hauber; S Y Le; J V Maizel; B R Cullen
Journal:  Nature       Date:  1989-03-16       Impact factor: 49.962

7.  The rev gene product of the human immunodeficiency virus affects envelope-specific RNA localization.

Authors:  M Emerman; R Vazeux; K Peden
Journal:  Cell       Date:  1989-06-30       Impact factor: 41.582

8.  Regulation of human immunodeficiency virus env expression by the rev gene product.

Authors:  M L Hammarskjöld; J Heimer; B Hammarskjöld; I Sangwan; L Albert; D Rekosh
Journal:  J Virol       Date:  1989-05       Impact factor: 5.103

9.  Temporal aspects of DNA and RNA synthesis during human immunodeficiency virus infection: evidence for differential gene expression.

Authors:  S Y Kim; R Byrn; J Groopman; D Baltimore
Journal:  J Virol       Date:  1989-09       Impact factor: 5.103

10.  Functional comparison of the Rev trans-activators encoded by different primate immunodeficiency virus species.

Authors:  M H Malim; S Böhnlein; R Fenrick; S Y Le; J V Maizel; B R Cullen
Journal:  Proc Natl Acad Sci U S A       Date:  1989-11       Impact factor: 11.205

View more
  39 in total

1.  CRM1-dependent function of a cis-acting RNA export element.

Authors:  Ileana Popa; Matthew E Harris; John E Donello; Thomas J Hope
Journal:  Mol Cell Biol       Date:  2002-04       Impact factor: 4.272

Review 2.  Evolution of feline immunodeficiency virus in Felidae: implications for human health and wildlife ecology.

Authors:  Jill Pecon-Slattery; Jennifer L Troyer; Warren E Johnson; Stephen J O'Brien
Journal:  Vet Immunol Immunopathol       Date:  2008-01-19       Impact factor: 2.046

3.  The feline immunodeficiency virus ORF-A gene facilitates efficient viral replication in established T-cell lines and peripheral blood lymphocytes.

Authors:  K Tomonaga; T Miyazawa; J Sakuragi; T Mori; A Adachi; T Mikami
Journal:  J Virol       Date:  1993-10       Impact factor: 5.103

4.  Biological characterization of Rev variation in equine infectious anemia virus.

Authors:  M Belshan; M E Harris; A E Shoemaker; T J Hope; S Carpenter
Journal:  J Virol       Date:  1998-05       Impact factor: 5.103

5.  Feline immunodeficiency virus Vif localizes to the nucleus.

Authors:  U Chatterji; C K Grant; J H Elder
Journal:  J Virol       Date:  2000-03       Impact factor: 5.103

Review 6.  Feline immunodeficiency virus: an interesting model for AIDS studies and an important cat pathogen.

Authors:  M Bendinelli; M Pistello; S Lombardi; A Poli; C Garzelli; D Matteucci; L Ceccherini-Nelli; G Malvaldi; F Tozzini
Journal:  Clin Microbiol Rev       Date:  1995-01       Impact factor: 26.132

7.  Two species of Rev proteins, with distinct N termini, are expressed by caprine arthritis encephalitis virus.

Authors:  A Gazit; P Mashiah; H Kalinski; A Gast; R Rosin-Abersfeld; S R Tronick; A Yaniv
Journal:  J Virol       Date:  1996-04       Impact factor: 5.103

8.  Posttranscriptional effector domains in the Rev proteins of feline immunodeficiency virus and equine infectious anemia virus.

Authors:  V A Mancuso; T J Hope; L Zhu; D Derse; T Phillips; T G Parslow
Journal:  J Virol       Date:  1994-03       Impact factor: 5.103

Review 9.  Human gene therapy vectors derived from feline lentiviruses.

Authors:  Román A Barraza; Eric M Poeschla
Journal:  Vet Immunol Immunopathol       Date:  2008-01-19       Impact factor: 2.046

Review 10.  Molecular mechanisms of FIV infection.

Authors:  John H Elder; Magnus Sundstrom; Sohela de Rozieres; Aymeric de Parseval; Chris K Grant; Ying-Chuan Lin
Journal:  Vet Immunol Immunopathol       Date:  2008-01-19       Impact factor: 2.046

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.